Crick — Clinical Intelligence Platform

Not applicableLooking for participantsNCT05584722

What this trial is testing

Risk and Resilience in Pulmonary Arterial Hypertension and Genetically Susceptible Individuals

Who this might be right for

Idiopathic Pulmonary Arterial HypertensionHeritable Pulmonary Arterial HypertensionUnaffected Mutation Carriers: Healthy Participants With a Known BMPR2 Gene Mutation and Normal Pulmonary Pressure and RV Function on Echo+1 more

Vanderbilt University Medical Center

Results for “Normal Physiology on Healthy Subjects”

Effects of Pinitol on Hidrocarbonated Metabolism Parameters in Diabetic, Impaired and Normal Fasting Glucose Subjects

The Effect of Lopinavir/Ritonavir on Endothelial Function

Influence of Different Degrees of Renal Impairment on the Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of BIBT 986 BS in Subjects With Normal Renal Function and Patients With Different Degrees of Renal Impairment

Investigate the Effect of Hepatic Impairment on the Pharmacokinetics and Safety and Tolerability of a Single Oral Dose of Risdiplam Compared to Matched Healthy Participants With Normal Hepatic Function

A Clinical Trial of Silk Peptide for the Evaluation of Efficacy on Immune Function

Impact of Hepatic Impairment on the Pharmacokinetics of Deferasirox.

Effects of Glucose-fructose Drinks During Training on Lactate Transport

Danoprevir in Healthy Volunteers And Patients With Hepatic Impairment

Effects of Yohimbine and Naltrexone on Sexual Function

The Effects of Atomoxetine on Cognition and Brain Function Based on Catechol-O-methyltransferase(COMT) Genotype

Evaluation of Renal Function Impairment on the Pharmacokinetics of LEE011

Erythromycin and Rivaroxaban in Study Participants With Normal and Reduced Kidney Function

Study of the Effect of Renal Impairment on the Pharmacokinetics of Vepoloxamer

Pilot Study: Effects of G-CSF on T Cell Function

The Effects of Increasing Caloric Intake on Diet-Induced Thermogenesis and 24h Energy Expenditure

Risk and Resilience in Pulmonary Arterial Hypertension and Genetically Susceptible Individuals

Assess the Safety of Experimental Medication BMS986165 in Participants With Normal Kidney Function and Participants With Mild to End-Stage Kidney Disease.

Study to Estimate the Effects of Hepatic Impairment on the Pharmacokinetics (PK) of PF-07321332

The Effect of Hepatic Impairment on The Pharmacokinetics of Aleglitazar

The Effect of Electronic Cleansing Toilet System (Bidet) on Anal Resting Pressure